Skip to main content
logo
Galectin Therapeutics Inc. (GALT)
NASDAQ: GALT · Real-Time Price · USD
4.610
+0.260 (5.98%)
At close: Sep 4, 2026, 4:00 PM EDT
4.690
+0.080 (1.74%)
After-hours: Sep 4, 2026, 7:58 PM EDT

Galectin Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
4652688110367123
Market Cap Growth
61.65%231.27%-21.14%52.89%-45.33%-3.92%
Enterprise Value
59638516314784109
Last Close Price
4.614.161.291.661.132.07

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PB Ratio
--2.12-0.79-1.70-2.0946.96
P/TBV Ratio
-----335.62

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
-1.05-1.09-1.03-1.21-1.2411.11
Net Debt / Equity Ratio
-0.95-0.95-0.89-0.78-0.66-4.05
Quick Ratio
0.092.210.431.641.434.39
Current Ratio
0.102.420.491.771.584.63
Return on Equity (ROE)
------227.74%
Return on Assets (ROA)
-64.18%-67.81%-116.08%-96.17%-75.96%-52.81%
Return on Capital Employed (ROCE)
11.40%-174.60%236.90%-304.00%-463.60%-92.00%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-6.03%-11.50%-58.11%-40.00%-57.74%-24.85%
Buyback Yield / Dilution
-3.55%-2.56%-3.57%-1.29%-1.48%-2.63%
SEC Filings: 10-K · 10-Q